Paul Wesley Noble MD
Interstitial Lung Diseases
Chairman, Department of Medicine, Cedars-Sinai Medical Center
Join to View Full Profile
8700 Beverly BlvdSte 2119West Hollywood, CA 90048
Phone+1 310-423-1888
Fax+1 310-423-2665
Dr. Noble is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1991
University of California (San Francisco)Chief Residency, Internal Medicine, 1987 - 1988- University of California (San Francisco)Residency, Internal Medicine, 1984 - 1987
New York University School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 2012 - 2026
NC State Medical License 2025 - 2026
CT State Medical License 1998 - 2007
MD State Medical License 1992 - 1999
CO State Medical License 1989 - 1993
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsMetastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment.Yoon Mee Yang, Jieun Kim, Zhijun Wang, Jina Kim, So Yeon Kim
The Journal of Clinical Investigation. 2025-02-13 - 2 citationsAging-Associated Molecular Changes in Human Alveolar Type I Cells.Xue Liu, Xuexi Zhang, Jiurong Liang, Paul W Noble, Dianhua Jiang
Journal of Respiratory Biology and Translational Medicine. 2024-09-01 - 7 citationsPanel stacking is a threat to consensus statement validity.Kasper P Kepp, Preben Aavitsland, Marcel Ballin, Francois Balloux, Stefan Baral
Journal of Clinical Epidemiology. 2024-09-01
Press Mentions
Pulmonary Fibrosis Foundation Adds Cedars-Sinai to Care Center NetworkDecember 23rd, 2022- Cedars-Sinai Named to Pulmonary Fibrosis Foundation Care Center NetworkDecember 16th, 2022
- Lassen Therapeutics Announces the Appointment of a Highly Experienced Biotech Executive to Its Board of Directors and the Expansion of Its Scientific and Clinical Advisory Board with Leading Experts in Pulmonary Fibrosis and Clinical DevelopmentOctober 7th, 2021
- Join now to see all
Grant Support
- ZIP8-dependent Zinc Metabolic Regulation in Alveolar Progenitor Cell Aging and FibrosisCEDARS-SINAI MEDICAL CENTER2022–2027
- Molecular Regulation of Progressive Pulmonary FibrosisCEDARS-SINAI MEDICAL CENTER2020–2027
- Innate Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2008–2012
- Matrix Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2011
- Regulation Of Pulmonary Fibrosis By CXCR3National Heart, Lung, And Blood Institute2006–2011
- Interdisciplinary Training Program In Lung DiseaseNational Heart, Lung, And Blood Institute2006–2011
- Mechanisms Of Macrophage Activation In Lung InflammationNational Heart, Lung, And Blood Institute2006–2010
- Matrix Regulation Of Fibroproliferative Lung DiseaseNational Heart, Lung, And Blood Institute2006–2010
- Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2006
- Survivin Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2006
- Regulation Of Pulmonary Fibrosis By CXCR3National Heart, Lung, And Blood Institute2005–2006
- Survivin Regulation Of Pulmonary FibrosisNational Heart, Lung, And Blood Institute2003–2005
- Immune Mechanisms In Non-Infectious Lung InflammationNational Institute Of Allergy And Infectious Diseases2002–2005
- Mechanisms Of Macrophage Activation In Lung InflammationNational Heart, Lung, And Blood Institute1997–2005
- Regulation Of Macrophage Phenotypes In Lung RepairNational Heart, Lung, And Blood Institute1992–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
